PhilipJRosenfeldMD
Ophthalmology • Miami, FLRetinal Disease
Professor of Ophthalmology, University of Miami School of Medicine
Dr. Rosenfeld is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
900 NW 17th Ave
Miami, FL 33101Phone+1 305-326-6031Fax+1 305-243-8470
Summary
- Medical retina specialist with a particular interest in macular degenerations
Education & Training
University of Miami/Jackson Health System/Bascom Palmer Eye InstituteResidency, Ophthalmology, 1995 - 1996
Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolResidency, Ophthalmology, 1992 - 1995
Johns Hopkins UniversityResidency, Obstetrics and Gynecology, 1988 - 1991- Johns Hopkins University School of MedicineClass of 1988
Certifications & Licensure
FL State Medical License 1995 - 2026
MD State Medical License 1991 - 1991- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014
- America's Top Doctors Castle Connolly, 2007-2014
- Top Doctors:South Florida Castle Connolly, 2012
- Join now to see all
Clinical Trials
- A Study of MSI-1256F (Squalamine Lactate) To Treat "Wet" Age-Related Macular Degeneration Start of enrollment: 2006 May 01
- Prospective OCT Study With Lucentis for Neovascular AMD (PrONTO Study) Start of enrollment: 2004 Aug 01
- An OCT-Guided Variable Dosing Regimen With Ranibizumab for the Treatment of Neovascular AMD Start of enrollment: 2004 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 4030 citationsRanibizumab for Neovascular Age-Related Macular DegenerationPhilip J. Rosenfeld, David M. Brown, Jeffrey S. Heier, David S. Boyer, Peter K. Kaiser
The New England Journal of Medicine. 2006-10-05 - 46 citationsCurrent Infectious Endophthalmitis Rates After Intravitreal Injections of Anti-Vascular Endothelial Growth Factor Agents and Outcomes of Treatment.Ninel Z. Gregori, Harry W. Flynn, Stephen G. Schwartz, Philip J. Rosenfeld, Kamyar Vaziri
Ophthalmic Surgery, Lasers & Imaging Retina. 2015-06-27 - 176 citationsUltrahigh-speed swept-source OCT angiography in exudative AMD.Eric M. Moult, WooJhon Choi, Nadia K. Waheed, Mehreen Adhi, ByungKun Lee
Ophthalmic Surgery, Lasers & Imaging Retina. 2014-11-01
Journal Articles
- Original Article Suspended Scattering Particles in Motion: A Novel Feature of OCT Angiography in Exudative MaculopathiesPhilip J Rosenfeld, Amir H Kashani, Kyle M Green, Julie Kwon, K Bailey Freund, David Sarraf, Nadia K Waheed, Carl B Rebhun, ScienceDirect
Press Mentions
Novel Therapies and New Biomarkers for Geographic AtrophyFebruary 1st, 2023- Age-Related Macular Degeneration: Nutrition, Genes and Deep Learning-the LXXVIEdward Jackson Memorial LectureJune 20th, 2020
International Practice Patterns for the Management of Acute Postsurgical and Postintravitreal Injection Endophthalmitis: European Vitreo-Retinal Society Endophthalmitis Study Report 1March 21st, 2020- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
